Cannabis withdrawal in cancer patients: a hidden struggle during transplant?
NCT ID NCT07594496
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find out how often cannabis withdrawal happens and how severe it is in patients with blood cancers who are hospitalized for a bone marrow transplant or CAR-T therapy. Researchers will track symptoms like mood changes and physical discomfort using a standard questionnaire. The goal is to better understand and manage withdrawal in this vulnerable group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Frailty check may steer safer cancer care for seniors
- Can a new PET tracer reveal hidden immune clues in tumors?
- Could gratitude exercises aid blood cancer recovery?
- Can a new tracer light up cancer growth?
- A hug in a blanket: could deep pressure calm cancer infusion anxiety?